Continuous Glucose Monitoring Metrics Using FreeStyle Libre3 in Patients with Type 2 Diabetes and Gastroparesis: A Pilot Prospective Investigator-Initiated Study
Authors' conclusion
Patients with T2D and GP showed distinct and altered CGM glucose metrics compared with those with T2D without GP. These findings highlight the need for better glycemic control in this population. Whether CGM metrics could help identify a specific biomarker for gastroparesis remains to be determined. Further validation with a broader population, including patients with T1D and GLP-1RAs, is necessary.
Study context
- Population
- Adults with T2D with or without gastroparesis using real-time CGM (rtCGM) FreeStyle Libre 3 for 4 weeks
- Participants
- 11 vs 20
- Exposure
- T2D with gastroparesis (GP) vs T2D without GP
- GPn = 11
- non-GPn = 20reference
- Outcome
- Mean CGM glucose
- Follow-up
- 4-week study
Methodological detailspilot, investigator-initiated
- Pilot
- Investigator-initiated
Main finding
As reported in the abstract
Observational data: associations, not effects.
Original publication
Continuous Glucose Monitoring Metrics Using FreeStyle Libre3 in Patients with Type 2 Diabetes and Gastroparesis: A Pilot Prospective Investigator-Initiated Study. Diabetes Technol Ther. Published 10 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →